Evidence map›Paper›PMID 28756468›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2018

The impact of cognitive insight, self-stigma, and medication compliance on the quality of life in patients with schizophrenia.

Yin-Ju Lien, Hsin-An Chang, Yu-Chen Kao, Nian-Sheng Tzeng, Chien-Wen Lu, Ching-Hui Loh

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Insight Paradox in Patients With Schizophrenia: A Concept Analysis.International journal of mental health nursing · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yin-Ju LienDepartment of Health Promotion and Health Education, National Taiwan Normal University, Taipei, Taiwan.
Hsin-An ChangDepartment of Psychiatry, Tri-Service General Hospital, Taipei, Taiwan.
Yu-Chen KaoDepartment of Psychiatry, National Defense Medical Center, Taipei, Taiwan. freud001@ms45.hinet.net.
Nian-Sheng TzengDepartment of Psychiatry, Tri-Service General Hospital, Taipei, Taiwan.
Chien-Wen LuDepartment of Psychiatry, Tri-Service General Hospital Songshan Branch, 131 Jiankang Road, Songshan District, Taipei, 10581, Taiwan.
Ching-Hui LohSchool of Medicine, National Defense Medical Center, Taipei, Taiwan.

Funding

National Science Council 102-2410-H-003-016
6 · The paper itself

Abstract

Impaired quality of life (QoL) is a common and clinically relevant feature of schizophrenia. In the present study, we attempted to formulate a model of QoL in the chronic stage of schizophrenia by including key variables-namely cognitive insight, self-stigma, insight into treatment, and medication compliance-that were proposed as its significant predictors in previous studies. We employed structural equation modeling (SEM) to simultaneously test the associations between these variables. A total of 170 community-dwelling patients with schizophrenia participated in this study. Cognitive insight, self-stigma, insight into treatment, medication compliance, and QoL were assessed through self-reporting. Symptoms were rated by interviewers. The influences of cognitive insight, stigma, insight into treatment, and medication compliance on QoL were supported using SEM. Our findings indicated that cognitive insight had a significant, positive, and direct effect on both self-stigma and insight into treatment; in contrast, it had a negative and direct effect on medication compliance. Notably, no evidence indicated a direct effect of cognitive insight on QoL. Thus, individuals with high cognitive insight reported low QoL because of stigma, low medication compliance, and their increased insight into treatment. In contrast, cognitive insight might indirectly ameliorate QoL mediated by the effect of insight into treatment on medication compliance. The findings provide additional support of the links between cognitive and clinical insight, self-stigma, medication compliance, and QoL in those with schizophrenia and suggest the need for screening and intervention services appropriate for this high-risk population.

Indexed as

Patient ComplianceSchizophrenic PsychologySocial StigmaAdultAgedCognition DisordersFemaleHumansMaleMiddle AgedPsychiatric Status Rating ScalesQuality of LifeSchizophreniaSelf ConceptSelf ReportStatistics, NonparametricInsightMedication complianceQuality of lifeRecoverySchizophreniaSelf-stigma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.